Page last updated: 2024-09-02

triptolide and Precursor Cell Lymphoblastic Leukemia-Lymphoma

triptolide has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, M; Jiang, Z; Kannappan, V; Li, P; Li, Y; Shi, P; Wang, W; Xu, B; Zhao, H1
Gu, L; Huang, M; Liu, T; Tian, D; Zhang, H; Zhou, M1

Other Studies

2 other study(ies) available for triptolide and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
    Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

    Topics: Adolescent; Adult; Aged; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Apoptosis; Caspase 9; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; Cytarabine; Diterpenes; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Histones; Humans; Inhibitory Concentration 50; Male; Membrane Potential, Mitochondrial; Mice, Inbred NOD; Mice, SCID; Middle Aged; Oxidative Stress; Phenanthrenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Young Adult

2016
Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Child; Diterpenes; Epoxy Compounds; Humans; Phenanthrenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2013